STING licensing of type I dendritic cells potentiates antitumor immunity
Jian Wang(Tianjin Medical University Cancer Institute and Hospital), Jinming Gao(Southwestern Medical Center)
Cited by 110
Related Papers
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
|Nature Communications|2022|384
Prolonged activation of innate immune pathways by a polyvalent STING agonist
|Nature Biomedical Engineering|2021|298
STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
|bioRxiv (Cold Spring Harbor Laboratory)|2024|5
Natural Product Trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer
|Unknown|2020|0
Lactate Increases Stemness of CD8 <sup>+</sup> T Cells to Augment Anti-Tumor Immunity
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0